Who are Late dexamethazone's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Medrol, Prelone, Methyl Prednisolonate, Methylprednisolone (drug), Dexamethasone (IV), Methylprednisolone (MP).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/late-dexamethazone.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Late dexamethazone — Competitive Intelligence Brief

Late dexamethazone (Late dexamethazone) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Glucocorticoid. Area: Immunology, Inflammation.

marketed Glucocorticoid Glucocorticoid receptor (GR) Immunology, Inflammation Small molecule Live · refreshed every 30 min

Target snapshot

Late dexamethazone (Late dexamethazone) — ClinAmygate. Dexamethasone is a synthetic glucocorticoid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors in the cytoplasm.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Late dexamethazone TARGET	Late dexamethazone	ClinAmygate	marketed	Glucocorticoid	Glucocorticoid receptor (GR)
Medrol	methylprednisolone	Generic (originally Upjohn/Pfizer)	marketed	Glucocorticoid (corticosteroid)	Annexin A1, Short transient receptor potential channel 5, Glucocorticoid receptor	1957-10-01
Prelone	prednisolone	Generic (originally Schering)	marketed	Glucocorticoid (corticosteroid)	Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1	1955-01-01
Methyl Prednisolonate	Methyl Prednisolonate	Ain Shams University	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
Methylprednisolone (drug)	Methylprednisolone (drug)	University Hospital, Bordeaux	marketed	Glucocorticoid (corticosteroid)	Glucocorticoid receptor (GR)
Dexamethasone (IV)	Dexamethasone (IV)	Cancer Trials Ireland	marketed	Glucocorticoid (corticosteroid)	Glucocorticoid receptor (GR)
Methylprednisolone (MP)	Methylprednisolone (MP)	Masonic Cancer Center, University of Minnesota	marketed	Glucocorticoid (corticosteroid)	Glucocorticoid receptor (GR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Glucocorticoid class)

Research in Real-Life Ltd · 2 drugs in this class
NICHD Neonatal Research Network · 2 drugs in this class
UMC Utrecht · 2 drugs in this class
University of Pennsylvania · 2 drugs in this class
First Affiliated Hospital of Zhejiang University · 1 drug in this class
GlaxoSmithKline · 1 drug in this class
ClinAmygate · 1 drug in this class
Instituto de Investigación Sanitaria y Biomédica de Alicante · 1 drug in this class
First Affiliated Hospital of Wenzhou Medical University · 1 drug in this class
Guangzhou JOYO Pharma Co., Ltd · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Late dexamethazone — Competitive Intelligence Brief. https://druglandscape.com/ci/late-dexamethazone. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab